+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


UMN Pharma Inc (4585) - Financial and Strategic SWOT Analysis Review

  • ID: 4278371
  • SWOT Analysis
  • March 2018
  • 25 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.


UMN Pharma Inc (UMN) is a biopharmaceutical company that manufactures therapeutic for diabetes, muscular dystrophy and influenza. The company’s products include UMN-0502, UMN-0501, UMN-0901, UMN-2003 and UMN-2002. Its UMN-0502 is a seasonal influenza vaccine. Its UMN-0501 and UMN-0901 are used as pandemic influenza vaccines. UMN provides UMN-2003 product, a norovirus VLP - rotavirus VP6 non-live injectable trivalent vaccine for preventing two major causative agents of acute gastroenteritis in one injection. It partners with universities and pharmeceutical compnias for biopharmaceuticals manufacturing, biosimilars business and otehrs. UMN is headquartered in Yokohama, Japan.

UMN Pharma Inc Key Recent Developments

Oct 31, 2017: UMN Pharma: Non-consolidated Financial Results for the First Nine Months of Fiscal Year Ending Dec. 31, 2017
Apr 28, 2017: UMN Pharma: Non-consolidated Financial Results for the First Three Months of Fiscal Year Ending Dec. 31, 2017
Feb 20, 2017: UNM Pharma: Revision of Consolidated Financial Results For the Fiscal Year Ending December 31, 2016

This comprehensive SWOT profile of UMN Pharma Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of UMN Pharma Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
Section 1 - About the Company
  • UMN Pharma Inc - Key Information
  • UMN Pharma Inc - Overview
  • UMN Pharma Inc - Key Employees
  • UMN Pharma Inc - Key Employee Biographies
  • UMN Pharma Inc - Key Operational Heads
  • UMN Pharma Inc - Major Products and Services
  • UMN Pharma Inc - History
  • UMN Pharma Inc - Company Statement
  • UMN Pharma Inc - Locations And Subsidiaries
  • UMN Pharma Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • UMN Pharma Inc - Business Description
  • UMN Pharma Inc - Corporate Strategy
  • UMN Pharma Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • UMN Pharma Inc - Strengths
  • UMN Pharma Inc - Weaknesses
  • UMN Pharma Inc - Opportunities
  • UMN Pharma Inc - Threats
  • UMN Pharma Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • UMN Pharma Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • UMN Pharma Inc, Key Information
  • UMN Pharma Inc, Key Ratios
  • UMN Pharma Inc, Share Data
  • UMN Pharma Inc, Major Products and Services
  • UMN Pharma Inc, History
  • UMN Pharma Inc, Key Employees
  • UMN Pharma Inc, Key Employee Biographies
  • UMN Pharma Inc, Key Operational Heads
  • UMN Pharma Inc, Other Locations
  • UMN Pharma Inc, Subsidiaries
  • UMN Pharma Inc, Key Manufacturing facilities
  • UMN Pharma Inc, Key Competitors
  • UMN Pharma Inc, SWOT Analysis
  • UMN Pharma Inc, Ratios based on current share price
  • UMN Pharma Inc, Annual Ratios
  • UMN Pharma Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • UMN Pharma Inc, Performance Chart
  • UMN Pharma Inc, Ratio Charts
Note: Product cover images may vary from those shown